This expanded study seeks to validate the prognostic significance of the HPGD, PACS1, and TDP2 cfRNA signature in a larger cohort of 52 CRC patients, using the Taqman quantitative PCR (qPCR) as the primary method for the gene expression analysis. The gene discussed is TDP2; the disease is colorectal carcinoma.